GlobalDeal

Stillmind Therapeutics

Biotechnology · San Francisco, United States

stillmindtx.com

About Stillmind Therapeutics

Stillmind Therapeutics is a biotechnology company focused on developing innovative therapies for neurological and psychiatric disorders. The company aims to address unmet medical needs through its proprietary drug development platform, which leverages advanced scientific research and clinical expertise. Stillmind is dedicated to improving the lives of patients suffering from conditions such as depression, anxiety, and other mental health issues. With a commitment to rigorous clinical trials and regulatory compliance, Stillmind Therapeutics strives to bring effective treatments to market while ensuring patient safety and efficacy.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Neuroscience, Drug Development, Clinical Research, Mental Health
Location
San Francisco, United States
Employees
1–10
Revenue (USD)
1–5M
Founded
2020

Products and services

Open Stillmind Therapeutics in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →